[Fatal course of agranulocytosis during antiarryhthmic aprindine therapy].
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D001073:Aprindine / Q000009:adverse effects* / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D005260:Female; D006801:Humans; D007192:Indenes / Q000009:adverse effects*
D007192:Indenes; D001073:Aprindine
Tödlich verlaufene Agranulozytose unter antiarrhythmischer Therapie mit Aprindin.